Prevention and Treatment of the “Big Four” Snakebite in India
Author:
Mukherjee Ashis K.
Publisher
Springer Singapore
Reference52 articles.
1. Alirol, E., Sharma, S. K., Ghimire, A., Poncet, A., Combescure, C., Thapa, C., Paudel, V. P., Adhikary, K., Taylor, W. R., & Warrell, D. (2017). Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal. PLOS Neglected Tropical Diseases, 11, e0005612. 2. Alirol, E., Sharma, S. K., Bawaskar, H. S., Kuch, U., & Chappuis, F. (2010). Snake bite in South Asia: A review. PLoS Neglected Tropical Diseases, 4(1), e603. 3. Amin, M., Mamun, S., Rashid, R., Rahman, M., Ghose, A., Sharmin, S., Rahman, M., & Faiz, M. (2008). Anti-snake venom: Use and adverse reaction in a snake bite study clinic in Bangladesh. Journal of Venomous Animals and Toxins including Tropical Diseases, 14, 660–672. 4. Chandrakumar, A., Suriyaprakash, T. N. K., LinuMohan, P., Thomas, L., & Vikas, P. V. (2016). Evaluation of demographic and clinical profile of snakebite casualties presented at a tertiary care hospital in Kerala. Clinical Epidemiology and Global Health, 4, 140–145. 5. Chanda, A., Kalita, B., Patra, A., Sandani, W. D., Senevirathne, T., & Mukherjee, A. K. (2018a). Proteomic analysis and antivenomics study of Western India Naja naja venom: Correlation between venom composition and clinical manifestations of cobra bite in this region. Expert Review of Proteomics, 16(2), 171–184.
|
|